anayamalik, Author at European Medical Journal - Page 64 of 120

Sexual Behavior Strongest Driver of Gut Microbiome in HIV

In a new study that challenges conventional assumptions about gut health in people living with HIV, researchers have found that sexual behavior has a stronger association with gut microbiome composition than either antiretroviral therapy (ART) regimens or weight changes.

Silent Threat: Third Cancers After Prostate Cancer Raise Mortality Risk

Prostate cancer survivors face a long-term threat that often goes undetected, a third primary cancer, according to new findings that highlight an under-recognized but serious risk with significant survival implications.

What Ambient AI Means for Epilepsy Clinics

Healthcare professionals and neurologists across the U.S. are closely watching the emergence of ambient AI tools in clinical practice, especially as these technologies enter specialized settings like epilepsy care.

GLP-1 Drugs May Curb Weight Gain After Quitting Smoking

GLP-1 receptor agonists (GLP-1 RAs), widely recognized for their role in metabolic disorders, may offer added support for smokers attempting to quit, according to findings presented at the 2025 American Psychiatric Association Annual Meeting.

1 in 10 Liver Transplant Patients Still Break Bones Despite Protocol

Liver transplant patients face a substantial risk of bone fractures despite following specialized care protocols, according to new findings.

Could Cannabis Be Harming the Skin?

As cannabis use continues to surge across the United States, a growing body of research is shedding light on its underrecognized dermatological consequences.

Cancer Risk Persists Despite HIV Treatment Success

A large international cohort study has found that people with HIV who achieve long-term virological suppression through antiretroviral therapy but experience suboptimal immune recovery are still at a significantly higher risk of developing cancer.

Delirium Misdiagnosis Common in Spanish-Speaking ICU Patients: ATS 2025

Commonly used ICU delirium screening tools often misclassify Spanish-speaking patients according to new research presented at 2025 American Thoracic Society International (ATS) Conference in San Francisco.

Surge in Stage I Diagnoses Tied to Treatment Delays

A new national study published ahead of print in JCO Oncology Practice reveals a steady increase in time to treatment initiation (TTI) across all 30 of the most prevalent cancer types, with early-stage diagnoses now a major driver of these delays.

Can MS Damage Be Reversed? Exploring Novel Interventions

In a newly published systematic review of clinical trials, researchers evaluated the safety and efficacy of interventions aimed at promoting remyelination in multiple sclerosis (MS), a neurodegenerative disease characterized by inflammation, demyelination, and axonal damage in the central nervous system.